IBM and the VA extended their precision oncology partnership in applying Watson technology to the treatment of veterans with late-stage cancer.

Viz.ai, an AI company developing software to detect strokes, has raised $21 million in venture capital to expand its reach to other conditions.

A new “venture philanthropy” accelerator is offering over $30 million in grants for new biomarkers and diagnostic tests for Alzheimer’s disease.

electroCore and UpScriptHealth will offer the former's gammaCore vagus nerve stimulation treatment through a telemedicine program.

Diassess was awarded a federal contract worth up to $21.9 million to develop an at-home flu diagnostic test.

Polares Medical raised $25 million to begin clinical testing of its transcatheter mitral valve repair/replacement system.

Packaging manufacturer Gerresheimer plans to acquire Sensile Medical to help it develop a line of electronic and connected drug delivery devices.

Royal Philips signed two long-term consultancy deals in Germany to supply equipment and reform workflows as it transitions to a solutions provider.

Already knowing Theranos’ story doesn’t make "Bad Blood" a less interesting read but offers a rare connection to its players as the scandal unfolds.

Verge Genomics raised $32 million to bring its AI-generated compounds to the clinic against ALS and Parkinson’s disease in the next three years.